| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 GPR101 OR2L13 ADGRG4 OR4M2B OR2T3 FZD8 OR51A7 OR4M2 TAS2R8 OR52A4P CELSR2 OR12D1 OR6C4 OR1Q1 OR6C75 OR52E1 TAS1R1 ADGRD2 ADGRD1 ADGRA3 | 5.25e-12 | 884 | 134 | 28 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | DDR1 OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 PLXND1 OR2H1 OR2T34 GPR101 OR2L13 ADGRG4 OR4M2B OR2T3 FZD8 OR51A7 OR4M2 TAS2R8 CSF2RB OR52A4P CELSR2 OR12D1 PTPRK OR6C4 OR1Q1 OR6C75 OR52E1 TAS1R1 ROS1 ADGRD2 ADGRD1 ADGRA3 | 5.47e-11 | 1353 | 134 | 33 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR4M2B OR2T3 OR51A7 OR4M2 OR52A4P OR12D1 OR6C4 OR1Q1 OR6C75 OR52E1 | 8.64e-11 | 431 | 134 | 19 | GO:0004984 |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 6.03e-05 | 32 | 134 | 4 | GO:0140142 | |
| GeneOntologyMolecularFunction | nuclear export signal receptor activity | 6.22e-05 | 12 | 134 | 3 | GO:0005049 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR4M2B OR2T3 OR51A7 OR4M2 TAS2R8 OR52A4P OR12D1 OR6C4 OR1Q1 OR6C75 OR52E1 TAS1R1 | 3.91e-12 | 485 | 131 | 21 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR4M2B OR2T3 OR51A7 OR4M2 TAS2R8 OR52A4P OR12D1 OR6C4 OR1Q1 OR6C75 OR52E1 TAS1R1 | 1.68e-11 | 524 | 131 | 21 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR4M2B OR2T3 OR51A7 OR4M2 OR52A4P OR12D1 OR6C4 OR1Q1 OR6C75 OR52E1 | 3.48e-11 | 432 | 131 | 19 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR4M2B OR2T3 OR51A7 OR4M2 TAS2R8 OR52A4P OR12D1 OR6C4 OR1Q1 OR6C75 OR52E1 TAS1R1 | 3.73e-11 | 547 | 131 | 21 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR4M2B OR2T3 OR51A7 OR4M2 TAS2R8 OR52A4P OR12D1 OR6C4 OR1Q1 OR6C75 OR52E1 TAS1R1 | 1.17e-10 | 582 | 131 | 21 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR4M2B OR2T3 OR51A7 OR4M2 OR52A4P OR12D1 OR6C4 OR1Q1 OR6C75 OR52E1 | 1.22e-10 | 465 | 131 | 19 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR4M2B OR2T3 OR51A7 OR4M2 TAS2R8 OR52A4P OR12D1 OR6C4 OR1Q1 OR6C75 OR52E1 TAS1R1 | 5.59e-09 | 722 | 131 | 21 | GO:0051606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 GPR101 OR2L13 ADGRG4 OR4M2B OR2T3 FZD8 OR51A7 OR4M2 TAS2R8 OR52A4P CELSR2 OR12D1 OR6C4 OR1Q1 OR6C75 OR52E1 TAS1R1 C3 ADGRD2 ADGRD1 ADGRA3 | 1.06e-08 | 1395 | 131 | 29 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception | OR2M2 OR10P1 OR5I1 OR2G3 ESPNL OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR4M2B OR2T3 OR51A7 OR4M2 TAS2R8 OR52A4P OR12D1 ELFN1 OR6C4 OR1Q1 OR6C75 OR52E1 TAS1R1 | 2.63e-07 | 1072 | 131 | 23 | GO:0007600 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in embryonic placenta development | 1.20e-04 | 3 | 131 | 2 | GO:0060671 | |
| GeneOntologyBiologicalProcess | epithelial cell morphogenesis involved in placental branching | 1.20e-04 | 3 | 131 | 2 | GO:0060672 | |
| HumanPheno | Abnormality of the dentition | GDF5 ERCC2 HIVEP2 ADAMTS3 USP9X HECTD4 CNKSR2 PLXND1 GPR101 GRHL2 ST14 TRAK1 IL1RAPL1 FAM20C C2CD3 ANAPC1 HERC2 GRHL3 RIC1 | 8.09e-06 | 1030 | 35 | 19 | HP:0000164 |
| HumanPheno | Abnormal number of teeth | GDF5 ADAMTS3 HECTD4 CNKSR2 PLXND1 GRHL2 TRAK1 FAM20C C2CD3 ANAPC1 GRHL3 RIC1 | 1.25e-05 | 421 | 35 | 12 | HP:0006483 |
| Domain | Olfact_rcpt | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR2T3 OR51A7 OR4M2 OR52A4P OR6C4 OR1Q1 OR6C75 | 1.06e-08 | 393 | 127 | 16 | IPR000725 |
| Domain | GPCR_Rhodpsn_7TM | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 GPR101 OR2L13 OR2T3 OR51A7 OR4M2 TAS2R8 OR52A4P OR6C4 OR1Q1 OR6C75 | 6.51e-07 | 670 | 127 | 18 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 GPR101 OR2L13 OR2T3 OR51A7 OR4M2 TAS2R8 OR52A4P OR6C4 OR1Q1 OR6C75 | 1.01e-06 | 691 | 127 | 18 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 GPR101 OR2L13 OR2T3 OR51A7 OR4M2 TAS2R8 OR52A4P OR6C4 OR1Q1 OR6C75 | 1.04e-06 | 692 | 127 | 18 | IPR000276 |
| Domain | GPS | 3.19e-06 | 34 | 127 | 5 | SM00303 | |
| Domain | GPCR_2_secretin-like | 3.25e-06 | 60 | 127 | 6 | IPR000832 | |
| Domain | GPCR_2-like | 3.25e-06 | 60 | 127 | 6 | IPR017981 | |
| Domain | 7tm_1 | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 GPR101 OR2L13 OR2T3 OR51A7 OR4M2 OR52A4P OR6C4 OR1Q1 OR6C75 | 3.41e-06 | 677 | 127 | 17 | PF00001 |
| Domain | IBN_N | 3.48e-06 | 16 | 127 | 4 | SM00913 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.59e-06 | 61 | 127 | 6 | PS50261 | |
| Domain | GPS | 3.70e-06 | 35 | 127 | 5 | PF01825 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 GPR101 OR2L13 OR2T3 OR51A7 OR4M2 OR52A4P OR6C4 OR1Q1 OR6C75 | 3.99e-06 | 685 | 127 | 17 | PS00237 |
| Domain | GPS | 4.28e-06 | 36 | 127 | 5 | PS50221 | |
| Domain | Importin-beta_N | 4.53e-06 | 17 | 127 | 4 | IPR001494 | |
| Domain | GPS | 4.92e-06 | 37 | 127 | 5 | IPR000203 | |
| Domain | GPCR_2_extracellular_dom | 7.30e-06 | 40 | 127 | 5 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 7.30e-06 | 40 | 127 | 5 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 7.30e-06 | 40 | 127 | 5 | PS50227 | |
| Domain | 7tm_2 | 2.23e-05 | 50 | 127 | 5 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.23e-05 | 50 | 127 | 5 | PS00650 | |
| Domain | IMPORTIN_B_NT | 1.06e-04 | 14 | 127 | 3 | PS50166 | |
| Domain | IBN_N | 1.32e-04 | 15 | 127 | 3 | PF03810 | |
| Domain | ARM-type_fold | 5.22e-04 | 339 | 127 | 9 | IPR016024 | |
| Domain | CP2 | 6.76e-04 | 6 | 127 | 2 | PF04516 | |
| Domain | CP2 | 6.76e-04 | 6 | 127 | 2 | IPR007604 | |
| Domain | PENTAXIN | 1.60e-03 | 9 | 127 | 2 | PS00289 | |
| Domain | - | CHL1 IGSF8 RELB PLXND1 IGSF10 IL1RAPL1 CSF2RB PTPRK ROS1 MYOM2 NCR1 ADGRA3 | 1.89e-03 | 663 | 127 | 12 | 2.60.40.10 |
| Domain | Ig_I-set | 1.91e-03 | 190 | 127 | 6 | IPR013098 | |
| Domain | I-set | 1.91e-03 | 190 | 127 | 6 | PF07679 | |
| Domain | A2M | 1.99e-03 | 10 | 127 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.99e-03 | 10 | 127 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.99e-03 | 10 | 127 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.99e-03 | 10 | 127 | 2 | PF07677 | |
| Domain | A2M_comp | 1.99e-03 | 10 | 127 | 2 | PF07678 | |
| Domain | A2M_N | 1.99e-03 | 10 | 127 | 2 | PF01835 | |
| Domain | A2M_N | 1.99e-03 | 10 | 127 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.99e-03 | 10 | 127 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.99e-03 | 10 | 127 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.99e-03 | 10 | 127 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.99e-03 | 10 | 127 | 2 | IPR001599 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR2T3 OR51A7 OR4M2 OR6C4 OR1Q1 OR6C75 OR52E1 | 2.28e-08 | 417 | 97 | 16 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR2M2 OR10P1 OR5I1 OR2G3 ESPNL OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR2T3 OR51A7 OR4M2 TAS2R8 OR6C4 OR1Q1 OR6C75 OR52E1 TAS1R1 | 5.32e-08 | 636 | 97 | 19 | M41834 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR2M2 OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR2L13 OR2T3 OR51A7 OR4M2 OR6C4 OR1Q1 OR6C75 | 6.17e-08 | 389 | 97 | 15 | M14091 |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR2M2 OR10P1 OR5I1 OR4E2 OR4M1 OR2H1 OR2L13 OR51A7 OR4M2 OR12D1 OR1Q1 OR6C75 | 9.11e-09 | 340 | 134 | 12 | 11875048 |
| Pubmed | OR2M2 OR10P1 OR5I1 OR4E2 OR4M1 OR2H1 OR2L13 OR51A7 OR4M2 OR12D1 OR1Q1 OR6C75 | 9.11e-09 | 340 | 134 | 12 | 11802173 | |
| Pubmed | OR2M2 OR10P1 OR5I1 OR4E2 OR4M1 OR2H1 OR2L13 OR51A7 OR4M2 OR12D1 OR1Q1 OR6C75 | 1.00e-08 | 343 | 134 | 12 | 32295537 | |
| Pubmed | OR2M2 OR10P1 OR5I1 OR4E2 OR4M1 OR2H1 OR2L13 OR51A7 OR4M2 OR12D1 OR1Q1 OR6C75 | 1.11e-08 | 346 | 134 | 12 | 14611657 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.71e-07 | 33 | 134 | 5 | 25713288 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 ERCC2 HIVEP2 ACACA EP400 WDR70 HECTD4 RELB CFAP43 PLXND1 ST14 TRAK1 FAM20C FASN C2CD3 CELSR2 HERC2 RIC1 | 2.70e-07 | 1105 | 134 | 18 | 35748872 |
| Pubmed | 2.95e-06 | 26 | 134 | 4 | 23181366 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 4.64e-06 | 29 | 134 | 4 | 15203201 | |
| Pubmed | OR10P1 OR5I1 OR2G3 OR4E2 OR4M1 OR2H1 OR2T34 OR51A7 OR4M2 OR6C4 OR1Q1 | 8.57e-06 | 541 | 134 | 11 | 14983052 | |
| Pubmed | cDNA cloning and expression analysis of new members of the mammalian F-box protein family. | 9.02e-06 | 11 | 134 | 3 | 10945468 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.41e-05 | 202 | 134 | 7 | 33005030 | |
| Pubmed | Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors. | 1.47e-05 | 2 | 134 | 2 | 37587872 | |
| Pubmed | Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. | 1.47e-05 | 2 | 134 | 2 | 22817897 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 19543203 | ||
| Pubmed | 3.03e-05 | 407 | 134 | 9 | 12693553 | ||
| Pubmed | The Asprosin-OLFR734 hormonal signaling axis modulates male fertility. | 4.41e-05 | 3 | 134 | 2 | 31798959 | |
| Pubmed | Multiple exportins influence thyroid hormone receptor localization. | 4.41e-05 | 3 | 134 | 2 | 25911113 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 21281598 | ||
| Pubmed | The deubiquitinase USP9X regulates RIT1 protein abundance and oncogenic phenotypes. | 4.41e-05 | 3 | 134 | 2 | 39161959 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 28714958 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 23382212 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 32337066 | ||
| Pubmed | PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer. | 4.41e-05 | 3 | 134 | 2 | 31399573 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 20584999 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 21726077 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 26069269 | ||
| Pubmed | Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate. | 4.41e-05 | 3 | 134 | 2 | 18455495 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 12549979 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 16831572 | ||
| Pubmed | USP34 ACACA USP9X IPO4 ECPAS FASN CSE1L XPO5 ANAPC1 HERC2 XPO7 | 4.80e-05 | 653 | 134 | 11 | 22586326 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HMBOX1 DDR1 HIVEP2 ACACA SPSB1 KIAA0232 WDR70 HECTD4 ECPAS GRHL2 BOD1L1 PATJ HPS5 ADGRD1 RIC1 CREB3L2 XPO7 | 6.16e-05 | 1489 | 134 | 17 | 28611215 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 8.80e-05 | 4 | 134 | 2 | 10469592 | |
| Pubmed | Disturbances in the normal regulation of SREBP-sensitive genes in PPAR alpha-deficient mice. | 8.80e-05 | 4 | 134 | 2 | 11254743 | |
| Pubmed | OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin. | 8.80e-05 | 4 | 134 | 2 | 31230984 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 17631500 | ||
| Pubmed | Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. | 8.80e-05 | 4 | 134 | 2 | 22682250 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 23669396 | ||
| Pubmed | 1.07e-04 | 24 | 134 | 3 | 24152035 | ||
| Pubmed | UPF2 is a critical regulator of liver development, function and regeneration. | 1.07e-04 | 24 | 134 | 3 | 20657840 | |
| Pubmed | 1.17e-04 | 282 | 134 | 7 | 23667531 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXN1 MAP7D3 EP400 RBL1 KTN1 WDR70 RELB ECPAS KBTBD7 FASN ANAPC1 XPO7 | 1.26e-04 | 857 | 134 | 12 | 25609649 |
| Pubmed | Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program. | 1.46e-04 | 5 | 134 | 2 | 37163372 | |
| Pubmed | 1.46e-04 | 5 | 134 | 2 | 10844590 | ||
| Pubmed | Regional neural tube closure defined by the Grainy head-like transcription factors. | 1.46e-04 | 5 | 134 | 2 | 20654612 | |
| Pubmed | 1.71e-04 | 28 | 134 | 3 | 8944226 | ||
| Pubmed | A Functional Link between AMPK and Orexin Mediates the Effect of BMP8B on Energy Balance. | 2.19e-04 | 6 | 134 | 2 | 27524625 | |
| Pubmed | HERC2 targets the iron regulator FBXL5 for degradation and modulates iron metabolism. | 2.19e-04 | 6 | 134 | 2 | 24778179 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 2.53e-04 | 79 | 134 | 4 | 12679517 | |
| Pubmed | 2.53e-04 | 320 | 134 | 7 | 28685749 | ||
| Pubmed | 2.91e-04 | 549 | 134 | 9 | 38280479 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | IGSF8 FAM234A USP9X KTN1 CACHD1 IPO4 ECPAS FASN CSE1L PTPRK XPO5 XPO7 | 2.98e-04 | 942 | 134 | 12 | 31073040 |
| Pubmed | 3.06e-04 | 7 | 134 | 2 | 27907249 | ||
| Pubmed | Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice. | 3.06e-04 | 7 | 134 | 2 | 27858140 | |
| Pubmed | 3.07e-04 | 34 | 134 | 3 | 26220403 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.16e-04 | 332 | 134 | 7 | 32786267 | |
| Pubmed | 3.57e-04 | 156 | 134 | 5 | 22008794 | ||
| Pubmed | 3.95e-04 | 37 | 134 | 3 | 10531035 | ||
| Pubmed | 4.06e-04 | 8 | 134 | 2 | 10925280 | ||
| Pubmed | Over-expression of Grhl2 causes spina bifida in the Axial defects mutant mouse. | 4.06e-04 | 8 | 134 | 2 | 21262862 | |
| Pubmed | 4.06e-04 | 8 | 134 | 2 | 24969029 | ||
| Pubmed | 4.24e-04 | 162 | 134 | 5 | 25826454 | ||
| Pubmed | 4.36e-04 | 708 | 134 | 10 | 39231216 | ||
| Pubmed | 4.98e-04 | 40 | 134 | 3 | 30865227 | ||
| Pubmed | 5.21e-04 | 9 | 134 | 2 | 37149635 | ||
| Pubmed | Identification of a link between Wnt/β-catenin signalling and the cell fusion pathway. | 5.21e-04 | 9 | 134 | 2 | 22109522 | |
| Pubmed | 5.21e-04 | 9 | 134 | 2 | 21081122 | ||
| Pubmed | Inhibition of Poly(ADP-Ribose) Polymerase-1 Protects Chronic Alcoholic Liver Injury. | 5.21e-04 | 9 | 134 | 2 | 27746183 | |
| Pubmed | 5.75e-04 | 98 | 134 | 4 | 16783635 | ||
| Pubmed | 5.75e-04 | 42 | 134 | 3 | 10531037 | ||
| Pubmed | 6.50e-04 | 10 | 134 | 2 | 25078604 | ||
| Pubmed | 6.50e-04 | 10 | 134 | 2 | 39296075 | ||
| Pubmed | RNF8/UBC13 ubiquitin signaling suppresses synapse formation in the mammalian brain. | 6.50e-04 | 10 | 134 | 2 | 29097665 | |
| Pubmed | 6.50e-04 | 10 | 134 | 2 | 34568787 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | FMO4 OR2M2 SPSB1 OR2G3 OR2T34 OR2L13 OR2T3 DENND2C TAS1R1 CFAP57 GRHL3 PATJ | 6.64e-04 | 1031 | 134 | 12 | 16710414 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 6.67e-04 | 179 | 134 | 5 | 36261009 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 7.19e-04 | 182 | 134 | 5 | 31067453 | |
| Pubmed | 7.37e-04 | 183 | 134 | 5 | 23956138 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | IGSF8 PIGN USP34 FAM234A KTN1 CACHD1 PLXND1 IGSF10 CELSR2 PTPRK SELENOI ADGRA3 CREB3L2 | 7.76e-04 | 1201 | 134 | 13 | 35696571 |
| Pubmed | Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. | 7.92e-04 | 11 | 134 | 2 | 14668353 | |
| Pubmed | 7.92e-04 | 11 | 134 | 2 | 9647694 | ||
| Pubmed | 7.92e-04 | 11 | 134 | 2 | 25775569 | ||
| Pubmed | CARM1 promotes adipocyte differentiation by coactivating PPARgamma. | 7.92e-04 | 11 | 134 | 2 | 18188184 | |
| Pubmed | 9.48e-04 | 12 | 134 | 2 | 25007825 | ||
| Pubmed | Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy. | 9.48e-04 | 12 | 134 | 2 | 24717294 | |
| Pubmed | 9.48e-04 | 12 | 134 | 2 | 27307439 | ||
| Pubmed | 1.03e-03 | 197 | 134 | 5 | 31620119 | ||
| Pubmed | 1.12e-03 | 13 | 134 | 2 | 7803821 | ||
| Pubmed | 1.12e-03 | 13 | 134 | 2 | 35075189 | ||
| Pubmed | Dependence of self-tolerance on TRAF6-directed development of thymic stroma. | 1.12e-03 | 13 | 134 | 2 | 15705807 | |
| Pubmed | 1.12e-03 | 13 | 134 | 2 | 26989192 | ||
| Pubmed | 1.12e-03 | 13 | 134 | 2 | 14506126 | ||
| Pubmed | 1.12e-03 | 13 | 134 | 2 | 8601493 | ||
| Pubmed | 1.23e-03 | 120 | 134 | 4 | 27320910 | ||
| Pubmed | 1.27e-03 | 55 | 134 | 3 | 22581228 | ||
| Pubmed | 1.30e-03 | 14 | 134 | 2 | 29183995 | ||
| Pubmed | 1.30e-03 | 14 | 134 | 2 | 25249504 | ||
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 1.30e-03 | 14 | 134 | 2 | 27626314 | |
| Pubmed | Genome-wide association study of biochemical traits in Korcula Island, Croatia. | 1.30e-03 | 14 | 134 | 2 | 19260141 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 1.48e-03 | 432 | 134 | 7 | 23455922 | |
| Pubmed | 1.48e-03 | 214 | 134 | 5 | 22199357 | ||
| Cytoband | 1q44 | 1.88e-05 | 110 | 134 | 5 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 3.90e-05 | 128 | 134 | 5 | chr1q44 | |
| Cytoband | 12q13.2 | 5.71e-04 | 55 | 134 | 3 | 12q13.2 | |
| GeneFamily | Exportins | 5.16e-06 | 7 | 97 | 3 | 547 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily D | 2.85e-05 | 2 | 97 | 2 | 914 | |
| GeneFamily | Olfactory receptors, family 2 | 3.25e-05 | 113 | 97 | 6 | 149 | |
| GeneFamily | Fibronectin type III domain containing | 2.22e-04 | 160 | 97 | 6 | 555 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.00e-03 | 9 | 97 | 2 | 1234 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.75e-03 | 161 | 97 | 5 | 593 | |
| GeneFamily | Ubiquitin specific peptidases | 3.38e-03 | 56 | 97 | 3 | 366 | |
| GeneFamily | Immunoglobulin like domain containing | 3.84e-03 | 193 | 97 | 5 | 594 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | ACACA CACHD1 GRHL2 NTN4 FASN PTPRK CFAP221 KCNJ15 C3 ROS1 PATJ | 8.21e-12 | 184 | 131 | 11 | 369b82f793deab672204558ae4e112cfa5aa9ccc |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | ACACA CACHD1 GRHL2 NTN4 FASN CFAP221 KCNJ15 C3 ROS1 USP54 PATJ | 1.23e-11 | 191 | 131 | 11 | 276455a64c2c3503d5048615762eb2ee37f0ac70 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.77e-10 | 191 | 131 | 10 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | ACACA CACHD1 GRHL2 NTN4 PTPRK CFAP221 KCNJ15 ROS1 USP54 PATJ | 2.92e-10 | 192 | 131 | 10 | 499e8893afea5e6d3371e0bd018f7e86a524d669 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.92e-10 | 192 | 131 | 10 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.86e-09 | 183 | 131 | 9 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.36e-09 | 190 | 131 | 9 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.61e-09 | 191 | 131 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.87e-09 | 192 | 131 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 6.14e-09 | 193 | 131 | 9 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.72e-09 | 195 | 131 | 9 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 6.39e-08 | 180 | 131 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 7.89e-08 | 185 | 131 | 8 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.89e-08 | 185 | 131 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 7.89e-08 | 185 | 131 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.23e-08 | 186 | 131 | 8 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.93e-08 | 188 | 131 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 8.93e-08 | 188 | 131 | 8 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 8.93e-08 | 188 | 131 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-07 | 191 | 131 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-07 | 191 | 131 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-07 | 192 | 131 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-07 | 192 | 131 | 8 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.09e-07 | 193 | 131 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.09e-07 | 193 | 131 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-07 | 193 | 131 | 8 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.14e-07 | 194 | 131 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-07 | 198 | 131 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-07 | 199 | 131 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-07 | 199 | 131 | 8 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-07 | 199 | 131 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-07 | 162 | 131 | 7 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.03e-06 | 179 | 131 | 7 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.11e-06 | 181 | 131 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-06 | 182 | 131 | 7 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.20e-06 | 183 | 131 | 7 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-06 | 183 | 131 | 7 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-06 | 184 | 131 | 7 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-06 | 184 | 131 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-06 | 186 | 131 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-06 | 186 | 131 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.38e-06 | 187 | 131 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-06 | 190 | 131 | 7 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.59e-06 | 191 | 131 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.65e-06 | 192 | 131 | 7 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.65e-06 | 192 | 131 | 7 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-06 | 192 | 131 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.71e-06 | 193 | 131 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-06 | 194 | 131 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.83e-06 | 195 | 131 | 7 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.83e-06 | 195 | 131 | 7 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 1.83e-06 | 195 | 131 | 7 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.96e-06 | 197 | 131 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-06 | 198 | 131 | 7 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-06 | 199 | 131 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-06 | 199 | 131 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.09e-06 | 199 | 131 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Biopsy_Control_(H.)-Epithelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.16e-06 | 200 | 131 | 7 | 0afd93c4fdcc118bcfa77f3b59f6ff7d9293a7a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.72e-06 | 151 | 131 | 6 | 29d91a7d1470121af45fb8bb35175f2acced4551 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.72e-06 | 151 | 131 | 6 | 9ebfbdccc9656fce8990d06622f225009633f07c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.69e-06 | 159 | 131 | 6 | a710551512aa0b7a281a81bea651a43c9f3b3539 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-06 | 161 | 131 | 6 | 4f25eeabb841b0b9204cdd4e71d5e131e7868184 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-06 | 161 | 131 | 6 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.18e-06 | 164 | 131 | 6 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.18e-06 | 164 | 131 | 6 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.84e-06 | 166 | 131 | 6 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.84e-06 | 166 | 131 | 6 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.13e-05 | 170 | 131 | 6 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-05 | 173 | 131 | 6 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-05 | 178 | 131 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-05 | 179 | 131 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.61e-05 | 181 | 131 | 6 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-05 | 182 | 131 | 6 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 1.71e-05 | 183 | 131 | 6 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-05 | 184 | 131 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-05 | 184 | 131 | 6 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 186 | 131 | 6 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.88e-05 | 186 | 131 | 6 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.88e-05 | 186 | 131 | 6 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-05 | 187 | 131 | 6 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-05 | 187 | 131 | 6 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.93e-05 | 187 | 131 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-05 | 187 | 131 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-05 | 187 | 131 | 6 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 188 | 131 | 6 | 6164d467b612767ceba15de34176bcc8e8c36ab8 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 1.99e-05 | 188 | 131 | 6 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 2.05e-05 | 189 | 131 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-05 | 189 | 131 | 6 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.11e-05 | 190 | 131 | 6 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 2.18e-05 | 191 | 131 | 6 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.24e-05 | 192 | 131 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 194 | 131 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.38e-05 | 194 | 131 | 6 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.45e-05 | 195 | 131 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | facs-Tongue|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 195 | 131 | 6 | 77128895db9221a64a171082d468ebcd6380c936 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.45e-05 | 195 | 131 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.52e-05 | 196 | 131 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-05 | 197 | 131 | 6 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.59e-05 | 197 | 131 | 6 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| Disease | 3-methylcytidine measurement | 1.71e-04 | 5 | 123 | 2 | EFO_0800633 | |
| Disease | muscular disease (implicated_via_orthology) | 1.71e-04 | 5 | 123 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 2.78e-04 | 75 | 123 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Mental Retardation, X-Linked 1 | 3.21e-04 | 32 | 123 | 3 | C2931498 | |
| Disease | adiponectin measurement | 3.74e-04 | 146 | 123 | 5 | EFO_0004502 | |
| Disease | cysteine measurement | 6.09e-04 | 9 | 123 | 2 | EFO_0021000 | |
| Disease | lower face morphology measurement | 1.14e-03 | 109 | 123 | 4 | EFO_0010948 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.52e-03 | 14 | 123 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Opioid use measurement | 1.75e-03 | 15 | 123 | 2 | EFO_0009937 | |
| Disease | developmental dysplasia of the hip | 1.99e-03 | 16 | 123 | 2 | EFO_1000648 | |
| Disease | metabolite measurement | 2.45e-03 | 560 | 123 | 8 | EFO_0004725 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 2.56e-03 | 65 | 123 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 2.81e-03 | 19 | 123 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | melanoma | 3.90e-03 | 248 | 123 | 5 | C0025202 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VHGLVLPLMLPSFYS | 756 | Q60I27 | |
| LPLMLPSFYSELFTL | 761 | Q60I27 | |
| SLYMFHPTLPRVLLE | 456 | Q9H0X4 | |
| MVHFLVPGISRPYLS | 1261 | Q96L91 | |
| PVEHMTFSPNYTVLL | 346 | Q8NDM7 | |
| PELHFIFLIVPSYMS | 131 | Q8NHU2 | |
| ITVQLPSPFHRMYTL | 331 | P0C7U0 | |
| MPTDAYHPIITNLTE | 271 | Q6QNK2 | |
| YSRITVPENMLSPTH | 1741 | Q8IZF6 | |
| LPSFYMTPSHRQVVF | 241 | Q8IWK6 | |
| PTISYPMLLHVAAQI | 736 | Q08345 | |
| TLMHPSLTRPYLLSE | 516 | Q5VU97 | |
| HLPLALGSPMYSIIT | 16 | P01024 | |
| YMPKSVHSSVPLLNS | 1901 | Q13085 | |
| NMRHTYLSPFTIVTP | 2151 | Q9HCU4 | |
| TFSTTPHMPTYLVAF | 296 | Q6Q4G3 | |
| TEPQYMVLVPSLLHT | 26 | P20742 | |
| VSMSRYIPHPFLVVS | 631 | Q4ADV7 | |
| YDPTAPTLFTMLDLL | 491 | Q01201 | |
| LDPHLTSPMYFLLAN | 51 | A0A0X1KG70 | |
| IRIDPHLQTPMYFFL | 51 | Q13606 | |
| SLQPYLLMAHFDVVP | 116 | Q6GTS8 | |
| MFTLFSYHPVPTEPL | 1086 | Q9H1A4 | |
| HPMFYFLAILSSIDP | 56 | Q8NGJ3 | |
| APVPYSSLSLDLFML | 846 | Q6ZVH7 | |
| PITPHEYMLSLYRTL | 166 | P43026 | |
| VVTEMYDTPTLSVHP | 116 | O76036 | |
| TNHTLRVMTPAVYAP | 766 | O00533 | |
| PMEILPHVRSSSEIY | 226 | Q14409 | |
| PHMVINSVATYLPIT | 2456 | Q2M2H8 | |
| HASYLAMSTPLSPVE | 1316 | O95714 | |
| EYLMYPLHSAPITGL | 381 | Q96MR6 | |
| MAFVPVIPESYSHVL | 1 | Q9UPZ3 | |
| EMILTATFHFYSEPP | 126 | P55107 | |
| LIPTLFHMKYPVESS | 141 | Q5VYK3 | |
| PVVLLETMSHYTDEP | 6 | Q6NT76 | |
| FSYVLPLVHSLEPTM | 976 | Q9Y4D7 | |
| MKAPIPHLILLYATF | 1 | Q9NZN1 | |
| YPGPVSVSEMSLLHA | 21 | Q92628 | |
| LFMYIRPTSDHSPTQ | 256 | Q96R28 | |
| LFIIKTEPSLHEPMY | 46 | Q8NH64 | |
| EPSLHEPMYIFLATL | 56 | A6NMU1 | |
| LDPHLTSPMYFLLAN | 51 | Q8NGD0 | |
| LDPHLTSPMYFLLAN | 51 | Q8NGB6 | |
| FIHTDPSRFMYTTPL | 771 | Q8IVL0 | |
| ILHPELTVDSMIPAY | 141 | Q8TB36 | |
| IVPDSSKPASMSHYL | 501 | P31512 | |
| PFLILPMTFYHVLDE | 246 | Q99712 | |
| PMTFYHVLDETSPLR | 251 | Q99712 | |
| LEMLPPELSFTILSY | 71 | Q9NRD0 | |
| IYPKILDFHPVTMAT | 466 | P18074 | |
| PLIHATTYIPLMDNA | 226 | Q86UP2 | |
| MALPHDSNETSYLLP | 1 | Q6ZNW5 | |
| IYTMPSPLTSFAHTK | 366 | Q8WVZ9 | |
| LSIIHPLSYPSKMTQ | 131 | Q96P66 | |
| YLFLLMHPSIISNLP | 611 | Q9H3R1 | |
| SEPRLHTPMYFFISQ | 56 | Q8NGX1 | |
| SEPRLHTPMYFFISQ | 56 | Q8NH03 | |
| FLPLVELRQTPMYTH | 3531 | Q9Y4D8 | |
| LTLLDPHLQTPMYFF | 46 | Q8NGE1 | |
| IVISDPRLHSPMYFF | 46 | P0DN82 | |
| LEVAMYQEPSLHSVP | 201 | Q92914 | |
| KPPSDSYYLIMLHFV | 241 | Q7L5A8 | |
| SHTMIPPATYSVALL | 2581 | Q8NFC6 | |
| APMVSVSSERHPLYN | 236 | Q9H461 | |
| RSLVMPTSLVPYHSE | 1081 | O15072 | |
| FIYSNLLHSTPMPAL | 1541 | Q6WRI0 | |
| TLGPEHLMPSSTYVA | 196 | P32927 | |
| ATVHYTRPMPDIDTL | 196 | Q9NQC8 | |
| YPYMHALDTLFVPLL | 571 | Q969P0 | |
| YETDLTPLESPTHLM | 96 | Q8TE85 | |
| TYFKTMPDLHSQPVL | 466 | Q6ISB3 | |
| YHPLPTTDMTENVLL | 176 | Q4AC94 | |
| STTLPFIMYELATHP | 311 | Q9HB55 | |
| EVPIVSPISRFTYHM | 71 | P61566 | |
| EVPTVSPISRFTYHM | 71 | P61567 | |
| QTPPYDSSHRILDVM | 431 | Q8IXL6 | |
| FVMLLPSSTHTIPFY | 411 | Q9Y3I1 | |
| MPSSTPLYHNAIKTI | 1096 | Q86UU0 | |
| TPDDVAISYLPLAHM | 296 | Q9ULC5 | |
| QHTYIPVLPASMIDI | 721 | Q68D51 | |
| IPLTVVAFIPYSVHM | 331 | Q9NQR9 | |
| SAPPVLFVVYSMHRA | 86 | Q8N144 | |
| TSFPYKIMPIQHTLS | 536 | Q8IWC1 | |
| SAVDTNPLSLYVMHP | 21 | Q9C0D9 | |
| PSDILELHPRVFYFM | 281 | Q9C0D9 | |
| YLMPGFIHLDSQPIS | 276 | Q86TM3 | |
| THLPPEVMLSIFSYL | 206 | Q9UKA1 | |
| AFHSYFMEAIAPPLL | 681 | P49327 | |
| QPHISSYSREVMPLL | 426 | Q8TEX9 | |
| ILALFPYLSVHMDPD | 381 | Q9UNU6 | |
| YPSATKMALPSQHSL | 401 | Q70SY1 | |
| LTLSDPHLQTPMYFF | 46 | A6NL08 | |
| HLPPYTNVSLKMILT | 456 | Q15262 | |
| HPFPIDIDYMISDTL | 966 | Q9HAU5 | |
| NPLTKHMAYPFLVLS | 251 | P03905 | |
| ILLTQVSPALHSPMY | 46 | Q8NGE3 | |
| SAPRLHIPMYIFLSN | 51 | Q15612 | |
| IIISYLDPPLHTPMY | 46 | Q8NGZ4 | |
| LDPPLHTPMYFFLSN | 51 | Q8NGZ4 | |
| PRLHSPMYFFLSDLS | 51 | Q9GZK4 | |
| DPRLHTPMYFLLSQL | 51 | Q8N349 | |
| TLLVPIHAYPVMNSL | 146 | Q4G0U5 | |
| ALATTVMPVPYSLEH | 46 | Q6ZR62 | |
| LPGVIMSLHPRYISF | 1006 | Q93008 | |
| MALPYHIFLFTVLLP | 1 | Q9UQF0 | |
| YFTHLIVMFKSPRPA | 126 | Q9HB63 | |
| MQPLSPISVHERYSS | 636 | P28749 | |
| LETLIFDMHSPYFPS | 491 | Q8N6K7 | |
| LHLTTLYSAFMELEP | 611 | O15353 | |
| QPLADLTIPVAMLHY | 141 | Q8IUH8 | |
| VAVTLAMLPHDYVAP | 776 | Q7Z7M1 | |
| YRFHTPPDILSSKSM | 126 | Q8NA57 | |
| PTHYSLLPSLQMDAL | 506 | Q8WXI2 | |
| SLLHSYTPKMAVIPS | 766 | Q9UPV9 | |
| LSYVPVFPSLLTDHM | 181 | Q6NUS8 | |
| NDIPSSYMALFPHLL | 676 | P55060 | |
| AALLSPFLVPMISYA | 156 | Q7RTX1 | |
| IIATVFTPSLHTPMY | 46 | Q8NGC2 | |
| SYMDHQTIFRVPSPL | 441 | Q7RTY8 | |
| LHLRNPYSFTPMLEE | 111 | Q8N2H3 | |
| ESFYPPAHQLSLDML | 541 | Q96DM3 | |
| LDMPPVSYDVQLLHS | 41 | Q96BD6 | |
| MELYPLSHIQEATPV | 886 | Q8NI35 | |
| TQDYIITPHALPMFR | 526 | Q9NW82 | |
| VTVYNTLSPMEPHAL | 276 | Q9Y5Y6 | |
| MPLHSPLSRYQSTVI | 111 | Q6ZNM6 | |
| LVSPILGPLFTYLHM | 911 | Q9HAV4 | |
| LISQDSPPVLYTFHM | 446 | Q8IYM2 | |
| SRHILAYSSVMQPFP | 1426 | P08922 | |
| TPHKTLMPYASLFQS | 516 | Q9BWV7 | |
| DIYFTSPLVHGMTPQ | 21 | O95427 | |
| ATEPHMLETYTPEVT | 396 | Q9UIA9 | |
| MFHVSKIPYFEPLTL | 171 | Q9NYW2 | |
| HFSFPLRLDMTPYTE | 2106 | Q70CQ2 | |
| LIQPTSYMTSKHLPE | 1171 | P31629 | |
| RMNSSPLFLHYVLIP | 296 | Q63HR2 | |
| LIPMPFVRLLSHTQY | 276 | Q9BXU2 | |
| ATSDPLPFIQMVHYI | 171 | Q70EL1 | |
| YTMISTLATFPPFLH | 176 | Q9P2D8 | |
| PLSSMIPYTHFDVQF | 266 | P54296 |